Results 241 to 250 of about 3,836,981 (277)
Some of the next articles are maybe not open access.

Application of the 2015 proposed NIOSH vapor containment performance protocol for closed system transfer devices used during pharmacy compounding and administration of hazardous drugs

Journal of Oncology Pharmacy Practice, 2018
Purpose The National Institute for Occupational Safety and Health (NIOSH) released a proposed protocol in 2015 to evaluate the vapor containment abilities of closed system transfer device technologies in order to provide meaningful comparisons between ...
Charlotte M Forshay   +3 more
semanticscholar   +1 more source

Toward atonement for pharmacy compounding tragedies

American Journal of Health-System Pharmacy, 2012
Can there be any satisfactory atonement for the recent deaths and suffering caused by fungal contamination of injections prepared by a large-scale pharmacy-compounding operation?[1][1],[2][2] Our legal system, of course, will gather the facts, apportion liability, and punish those responsible ...
openaire   +2 more sources

Regulating Compounding Pharmacies.

NCSL legisbrief, 2015
(1) The Pew Charitable Trusts identified 27 compounding incidents that resulted in 89 deaths since 2001. (2) Unlike drug manufacturers, compounding pharmacies are generally not required to report adverse events associated with their products to the FDA. (3) Federal law on drug compounding was updated in 2013 to create a new group of compounders called "
openaire   +2 more sources

Regulating Compounding Pharmacies after NECC

New England Journal of Medicine, 2012
FDA rules are often forged in crisis. Compounding pharmacies are at the center of a controversy after an outbreak of fungal meningitis that was traced to methylprednisolone acetate from the New England Compounding Center. Congress is already discussing new regulations.
openaire   +2 more sources

Indocyanine green availability from compounding pharmacies

American Journal of Health-System Pharmacy, 2008
Indocyanine green for injection (IC-Green, Akorn Inc., Buffalo Grove, IL) is a sterile, lyophilized green powder dye containing 25 mg of drug with no more than 5% sodium iodide. The drug is used for several diagnostic purposes, including determining cardiac output and hepatic function, and ...
Richard, Cramer   +2 more
openaire   +2 more sources

NABP to inspect compounding pharmacies

American Journal of Health-System Pharmacy, 2013
The National Association of Boards of Pharmacy (NABP) in December launched a nationwide program to identify and inspect compounding pharmacies. NABP Executive Director Carmen Catizone, speaking December 5 at ASHP’s Midyear Clinical Meeting in Las Vegas, said critical information about ...
openaire   +1 more source

Compounding from a Pharmacy Student's Perspective: Staying Competitive as a Compounding Pharmacy.

International journal of pharmaceutical compounding, 2019
The International Academy of Compounding Pharmacists Foundation held a student essay contest in the Spring of 2018. Two great submissions were chosen to receive an award. This article features one of the chosen essays, which discusses some of the challenges that compounding pharmacies face in the competitive profession of pharmacy.
openaire   +1 more source

Carbowax Compounds in Pharmacy

Journal of the American Pharmaceutical Association (Practical Pharmacy ed.), 1949
C P, McCLELLAND, R L, BATEMAN
openaire   +2 more sources

[Pharmacy compounding of an omeprazole suspension].

Journal de pharmacie de Belgique, 2009
The problems of preparation of different pharmaceutically compounded formulations of prescribed omeprazole suspensions are discussed. Problems that can be cited are: inadequate preparation, chemical and physical stability problems, taste problems and low bioavailability. The formulation of the omeprazole suspension is optimized, taking into account the
F, Van Der Straeten   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy